Beta-ray brachytherapy of retinoblastoma: Feasibility of a new small-sized ruthenium-106 plaque

Ophthalmic Research

Volumn 38, Issue 1, 2005, Pages 8-12

  Schueler, Andreas O ^a   Flühs, Dirk ^a   Anastassiou, Gerasimos ^a   Jurklies, Christine ^a   Sauerwein, Wolfgang ^a   Bornfeld, Norbert ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Brachytherapy; Radiation; Retinoblastoma; Ruthenium

Indexed keywords

CONTRAST MEDIUM; RUTHENIUM 106;

ARTICLE; BETA RADIATION; BRACHYTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DISEASE COURSE; DOSIMETRY; ENDOPHYTE; EYE TUMOR; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HEMORRHAGE; MALE; OPTIC DISK; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; RETINOBLASTOMA; SCLERA; TREATMENT INDICATION; TUMOR RECURRENCE; TUMOR REGRESSION; TUMOR VOLUME; VITREOUS BODY; VITREOUS DISEASE;

BETA RAYS; BRACHYTHERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; RUTHENIUM RADIOISOTOPES; TREATMENT OUTCOME;

EID: 29144497175     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088259     Document Type: Article

References (17)

1. Moore RF, Stallard HB, Milner JG: Retinal glioma treated by radon seeds. Br J Ophthalmol 1931;15:673-696.
2. Stallard HB: Radiotherapy of malignant intraocular neoplasms. Br J Ophthalmol 1948;32:619-639.
3. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B: Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology 2001;108:2116-2121.
4. Shields JA, Giblin ME, Shields CL, Markoe AM, Karlsson U, Brady LW, Amendola BE, Woodleigh R: Episcleral plaque radiotherapy for retinoblastoma. Ophthalmology 1989;96:530-537.
5. Merchant TE, Gould CJ, Wilson MW, Hilton NE, Rodriguez-Galindo C, Haik BG: Episcleral plaque brachytherapy for retinoblastoma. Pediatr Blood Cancer 2004;43:134-139.
6. Lommatzsch P, Vollmar R: Ein neuer Weg zur konservativen Therapie intraokularer Tumoren mit Betastrahlen (Ruthenium 106) unter Erhaltung der Sehfähigkeit. Klin Monatsbl Augenheilkd 1966;148:682-699.
7. 106Rh applicators. Mod Probl Ophthalmol 1977;18:128-136.
8. Fledelius HC, Christensen AC: Reappraisal of the human ocular growth curve in fetal life, infancy, and early childhood. Br J Ophthalmol 1996;80:918-921.
9. Fluhs D, Anastassiou G, Wening J, Sauerwein W, Bornfeld N: The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators. Med Phys 2004;31:1481-1488.
10. Cross WG, Hokkanen J, Jarvinen H, Mourtada F, Sipila P, Soares CG, Vynckier S: Calculation of beta-ray dose distributions from ophthalmic applicators and comparison with measurements in a model eye. Med Phys 2001;28:1385-1396.
11. Soares CG, Vynckier S, Jarvinen H, Cross WG, Sipila P, Fluhs D, Schaeken B, Mourtada FA, Bass GA, Williams TT: Dosimetry of beta-ray ophthalmic applicators: comparison of different measurement methods. Med Phys 2001;28:1373-1384.
12. Schueler AO, Jurklies C, Heimann H, Wieland R, Havers W, Bornfeld N: Thermochemotherapy in hereditary retinoblastoma. Br J Ophthalmol 2003;87:90-95.
13. Shields JA, Parsons H, Shields CL, Giblin ME: The role of cryotherapy in the management of retinoblastoma. Am J Ophthalmol 1989;108:260-264.
14. Shields CL, Shields JA, Kiratli H, De Potter PV: Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus 1995;32:317-322.
15. Shields CL, Shields JA: Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999;36:8-18, quiz 35-36.
16. Goto H, Kousaka A, Takano S, Usui M: Recurrence of retinoblastoma 12 years after brachytherapy. Am J Ophthalmol 2002;134:773-775.
17. Buys RJ, Abramson DH, Ellsworth RM, Haik B: Radiation regression patterns after cobalt plaque insertion for retinoblastoma. Arch Ophthalmol 1983;101:1206-1208.